FY2018 EPS Estimates for Tivity Health Inc Increased by Jefferies Group (TVTY)

Tivity Health Inc (NASDAQ:TVTY) – Stock analysts at Jefferies Group raised their FY2018 EPS estimates for shares of Tivity Health in a note issued to investors on Thursday. Jefferies Group analyst D. Styblo now expects that the company will post earnings of $2.14 per share for the year, up from their previous estimate of $1.77. Jefferies Group also issued estimates for Tivity Health’s FY2019 earnings at $2.35 EPS.

Tivity Health (NASDAQ:TVTY) last issued its earnings results on Thursday, October 26th. The company reported $0.46 earnings per share for the quarter, topping the Zacks’ consensus estimate of $0.36 by $0.10. The business had revenue of $137.70 million for the quarter, compared to the consensus estimate of $137.95 million. Tivity Health had a net margin of 11.45% and a return on equity of 30.23%. Tivity Health’s revenue was up 10.2% on a year-over-year basis.

Other equities analysts also recently issued reports about the stock. BidaskClub downgraded shares of Tivity Health from a “buy” rating to a “hold” rating in a report on Thursday, January 4th. Chardan Capital restated a “neutral” rating and set a $44.00 target price (up from $40.00) on shares of Tivity Health in a report on Friday, October 27th. Barrington Research restated an “outperform” rating and set a $40.00 target price (down from $46.00) on shares of Tivity Health in a report on Tuesday, November 7th. Zacks Investment Research upgraded shares of Tivity Health from a “sell” rating to a “hold” rating in a report on Friday, January 12th. Finally, SunTrust Banks set a $50.00 target price on shares of Tivity Health and gave the stock a “buy” rating in a report on Friday, October 27th. Three research analysts have rated the stock with a hold rating and seven have given a buy rating to the company’s stock. Tivity Health currently has an average rating of “Buy” and a consensus price target of $45.25.

Tivity Health (NASDAQ:TVTY) opened at $39.70 on Monday. The firm has a market cap of $1,570.00, a price-to-earnings ratio of 25.45, a P/E/G ratio of 2.14 and a beta of 0.18. Tivity Health has a fifty-two week low of $23.13 and a fifty-two week high of $48.50. The company has a current ratio of 0.60, a quick ratio of 0.60 and a debt-to-equity ratio of 0.02.

Several large investors have recently added to or reduced their stakes in TVTY. Flinton Capital Management LLC increased its holdings in shares of Tivity Health by 63.5% in the second quarter. Flinton Capital Management LLC now owns 3,502 shares of the company’s stock valued at $139,000 after purchasing an additional 1,360 shares during the last quarter. Riverhead Capital Management LLC increased its holdings in shares of Tivity Health by 69.7% in the second quarter. Riverhead Capital Management LLC now owns 3,564 shares of the company’s stock valued at $142,000 after purchasing an additional 1,464 shares during the last quarter. SG Americas Securities LLC acquired a new position in shares of Tivity Health in the third quarter valued at $210,000. Crossmark Global Holdings Inc. bought a new stake in shares of Tivity Health in the third quarter valued at about $279,000. Finally, Piedmont Investment Advisors LLC bought a new stake in shares of Tivity Health in the second quarter valued at about $290,000.

In other Tivity Health news, insider Mary Flipse sold 5,000 shares of the company’s stock in a transaction on Friday, November 3rd. The shares were sold at an average price of $48.11, for a total value of $240,550.00. Following the transaction, the insider now directly owns 45,167 shares in the company, valued at $2,172,984.37. The transaction was disclosed in a filing with the SEC, which is available through the SEC website. Also, CAO Glenn Hargreaves sold 5,805 shares of the company’s stock in a transaction on Thursday, November 2nd. The shares were sold at an average price of $45.15, for a total transaction of $262,095.75. Following the completion of the transaction, the chief accounting officer now owns 44,448 shares in the company, valued at $2,006,827.20. The disclosure for this sale can be found here. Over the last quarter, insiders sold 875,892 shares of company stock worth $31,815,642. Corporate insiders own 8.42% of the company’s stock.

COPYRIGHT VIOLATION NOTICE: “FY2018 EPS Estimates for Tivity Health Inc Increased by Jefferies Group (TVTY)” was originally reported by American Banking News and is the sole property of of American Banking News. If you are reading this news story on another publication, it was stolen and reposted in violation of United States & international copyright laws. The original version of this news story can be accessed at https://www.americanbankingnews.com/2018/01/29/fy2018-eps-estimates-for-tivity-health-inc-increased-by-jefferies-group-tvty.html.

Tivity Health Company Profile

Tivity Health, Inc, formerly Healthways, Inc, is focused targeted population health for those aged 50 and older. The Company offers three programs: SilverSneakers senior fitness, Prime fitness and WholeHealth Living. The SilverSneakers senior fitness program is offered to members of Medicare Advantage, Medicare Supplement, and Group Retiree plans.

Earnings History and Estimates for Tivity Health (NASDAQ:TVTY)

Receive News & Ratings for Tivity Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Tivity Health and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply